Biomarker and DNA Collection in Subjects Participating in Protocol 22003

Clinical trial NCT00892580 · COMPLETED

Trial details

NCT number: NCT00892580
Sponsor: Seaside Therapeutics, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Fragile X Syndrome

Start date: 2009-05-01
Primary completion: 2010-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.